Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistent Olfactory and Gustatory Dysfunctions Due to Different SARS-CoV-2 Variants: Clinical Characteristics and Treatment

NCT06208540 is registered in ClinicalTrials.gov with Sherifa Ahmed Hamed as lead sponsor.

NCT NCT06208540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06208540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistent Olfactory and Gustatory Dysfunctions Due to Different SARS-CoV-2 Variants: Clinical Characteristics and Treatment
Lead sponsor
Sherifa Ahmed Hamed
Phase
Phase 4
Overall status
Completed
Start date
August 30, 2021
Completion date
May 30, 2024
Enrollment
160 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

post-covid-19 persistent smell and taste disorders